Module 5 Study & Drug Development Flashcards

Study & Drug Development

1
Q

This phase of study uses only a few small doses of a new drug in a few people. They often test how the drug acts in the human body and how it responds.

A

PHASE 0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

This phase of studies of a new drug are usually the first that involve people. These studies are done to find the highest dose of the new treatment…

A

PHASE 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The trials in this phase are designed to see if the investigational product works in participants with the disease of condition under investigation.

A

PHASE 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

These trials involve several hundred to several thousand participants. They are intended to answer the question question, is this treatment as improvement?

A

PHASE 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the importance of bench evidence in drug development

A

To determine the stability of the drug during shipment and storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the importance of preclinical evidence in drug development

A

To provide initial safety data for FDA approval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The trials in the phase study the side effects caused over time by a new treatment after it has been approved and is on the market

A

PHASE 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Can endpoints include all types of data capture. i.e. quality of life surveys, specimen samples needed at specific timepoints?

A

YES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the benefit of using schemas in clinical trials

A

They help plan for the intensity and timeline of the study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why are test schedules important in clinical trials

A

The provide a detailed list of required tests and procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F
The main difference between the observational and experimental study design is that observational studies don’t include any interventions while experimental studies involve adding a treatment or procedure

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a randomized clinical trial (RCT) used for in experimental study designs?

A

To compare the results between a control group and a control group and a treatment group.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is single blinding in clinical trials

A

only the participant is blinded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is double blinding in clinical trials

A

participant and study team are blinded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is triple blinding in clinical trials

A

participant, study team, and data interpreters are blinded.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F
A placebo is generally used when the treatment period is short and lack of treatment of the medical condition is not expected to have clinically relevant impact

17
Q

Eliquis is being monitored for long-term safety and effectiveness in preventing blood clots.

Which phase of clinical trial is this?

18
Q

T/F
The primary objective of Phase 3 trials is to test to see if the drug is an improvement from the current standard

19
Q

A description of the trial design should include (3)

A

A description of (3)

  1. Specific statement of the primary endpoints and the secondary endpoints, if any, to be measured during the trial
  2. Measures taken to minimize/avoid bias
  3. the type/design of the trial to be conducted and a schematic diagram of trial design, procedures, and stages.
20
Q

T/F
Pragmatic trials aim to test whether an intervention works under optimal situations

21
Q

Which phase of clinical trials primarily focuses on assessing the safety and dosage of a new drug in a small group of healthy volunteers?